Simplex Trading, LLC Obs Eva Sa Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.08 - $0.23 $5,469 - $15,725	-68,371 Reduced 97.87%	1,489 $0
Q4 2022 Feb 02, 2023	SELL	$0.14 - $0.21 $1,388 - $2,082	-9,916 Reduced 12.43%	69,860 $9,000
Q3 2022 Nov 04, 2022	SELL	$0.14 - $1.83 $2,907 - $38,005	-20,768 Reduced 20.66%	79,776 $11,000
Q2 2022 Aug 03, 2022	BUY	$1.34 - $2.08 $52,590 - $81,633	39,247 Added 64.03%	100,544 $161,000
Q1 2022 May 02, 2022	BUY	$1.1 - $2.17 $20,495 - $40,431	18,632 Added 43.67%	61,297 $92,000
Q2 2021 Aug 12, 2021	SELL	$2.56 - $3.35 $42,101 - $55,094	-16,446 Reduced 27.82%	42,665 $129,000
Q1 2021 Apr 26, 2021	BUY	$2.01 - $5.05 $92,612 - $232,683	46,076 Added 353.48%	59,111 $192,000
Q4 2020 Feb 02, 2021	BUY	$1.89 - $2.55 $16,314 - $22,011	8,632 Added 196.05%	13,035 $27,000
Q3 2020 Oct 14, 2020	BUY	$2.46 - $6.15 $7,616 - $19,040	3,096 Added 236.88%	4,403 $10,000
Q2 2020 Jul 13, 2020	BUY	$2.01 - $5.95 $2,627 - $7,776	1,307 New	1,307 $7,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.